Skip to main content
ALGORAE PHARMACEUTICALS LIMITED logo

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,159 across all filing types
Latest filing 2012-08-05 Director's Dealing
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 72.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in shareholding, including the number of shares held before and after the change, the nature of the transaction (on-market trade), and dates. This matches the definition of a Director's Dealing report, which involves personal share transactions by company directors and executives. The document is relatively short and focused solely on this transaction, with no financial statements or broader company information. Therefore, it fits the 'Director's Dealing' category (DIRS).
2012-08-05 English
Change of Director's Interest Notice 2 pages 73.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in shareholding, including the number of shares held before and after the change, the nature of the transaction (on-market trade), and dates. The document is short (3277 characters) and focuses solely on the director's personal share transactions. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades).
2012-07-23 English
Appendix 4C - quarterly 7 pages 104.1KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly Cash Flow Report 30 June 2012' and contains detailed quarterly cash flow statements, including operating, investing, and financing activities. It references the quarter ended 30 June 2012 and provides substantive financial data such as cash flows, payments to directors, reconciliation of cash, and compliance statements. The document is over 12,000 characters, indicating it is a full report rather than a brief announcement. The Appendix 4C is a recognized quarterly report format used by entities admitted on the basis of commitments, consistent with interim or quarterly financial reporting. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q4 2012
2012-07-22 English
Change of Director`s Interest Notice 2 pages 72.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's change in shareholding, including the number of shares held before and after the change, the nature of the transaction (on-market trade), and dates. This matches the description of a Director's Dealing report, which reports personal share transactions by company directors and executives. The document is short and specific to a director's share transaction, not a broader financial or management report.
2012-06-05 English
LCT restructures for next stage of growth 2 pages 209.6KB
Board/Management Information Classification · 95% confidence The document is a company announcement from Living Cell Technologies Limited dated 1 June 2012. It discusses a restructuring involving management roles, specifically the consolidation of Medical Director and Head of Research and Development into a Chief Science and Medical Officer position, and mentions personnel changes. There is no financial data, no discussion of financial results, no regulatory filings, no voting results, no legal proceedings, no capital changes, and no mention of a report being attached or published. The content focuses on changes in senior management roles and organizational structure. Therefore, the document fits best under the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2012-05-31 English
LCT`s DIABECELL trial extension approved 2 pages 45.1KB
Regulatory Filings Classification · 95% confidence The document is a company announcement from Living Cell Technologies Limited regarding the approval to extend a Phase 2 clinical trial for their DIABECELL product. It provides details about the trial extension, dosage groups, and future plans for the trial. There are no financial statements, regulatory filings, or detailed financial performance data. The content is focused on clinical trial progress and company updates rather than financial results or governance. It is not an Annual Report, Earnings Release, or any financial report. It is also not a regulatory filing or a report publication announcement. The document is best classified as a general company announcement related to clinical trial progress, which fits under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2012-05-16 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.